Helping hospitals protect patients against an emerging public health threat
ST. PAUL, Minn.--(BUSINESS WIRE)--Ecolab Inc., the global leader in water, hygiene and energy technologies and services that protect people and vital resources, has received U.S. Environmental Protection Agency (EPA) approval for its OxyCide™ Daily Disinfectant Cleaner for efficacy against Candida auris (C. auris), an emerging fungal pathogen that presents a serious global health threat.
According to the U.S. Centers for Disease Control and Prevention (CDC), C. auris is difficult to identify, multi-drug resistant and can spread through sick patients as well as on contaminated surfaces and equipment, putting hospitalized patients and hospital systems at risk for outbreaks.1,2
C. auris has been cultured from multiple locations in patient rooms, including both high touch surfaces, such as bedside tables and bedrails, and locations further away from the patient. C. auris has also been identified on mobile equipment, such as glucometers, temperature probes, blood pressure cuffs, ultrasound machines, nursing carts and crash carts.3
“C. auris is an increasing risk, and is one of 34 different organisms that can be killed through the use of OxyCide Daily Disinfectant Cleaner,” said Christopher Smith, Ecolab senior vice president and general manager for Healthcare in North America. “Hospitals throughout the country are realizing the benefits of using OxyCide within their facilities.”
OxyCide Daily Disinfectant Cleaner is an EPA-registered one-step disinfectant cleaner, virucide and deodorizer with sporicidal activity designed for daily hospital use on both flexible and hard non-porous surfaces. When used as directed, it is proven effective in preventing healthcare-associated infections (HAIs); killing C. auris in three minutes as well as Clostridioides difficile (C. diff) and 32 other organisms in five minutes or less.
Designed for daily, discharge and isolation cleaning, OxyCide Daily Disinfectant Cleaner enables product standardization and workflow simplification by replacing multiple products with one solution. The diluted product, when used according to label instructions, requires no personal protective equipment (PPE), and OxyCide Daily Disinfectant Cleaner active ingredients hydrogen peroxide and peracetic acid provide favorable material compatibility that helps minimize damage to surfaces, including stainless steel, computer screens, mattresses and blood pressure cuffs. It does not leave residual films or salts behind, require rinsing, or bleach fabrics.
The OxyCide Daily Disinfectant Cleaner claim against C. auris is currently being reviewed by state agencies, including the California Department of Pesticide Regulation (CDPR).
OxyCide Daily Disinfectant Cleaner is a proactive approach to help prevent the spread of C. auris and C. difficile, and one among a portfolio of Ecolab Healthcare solutions designed to address critical needs in the hospital environment. Ecolab Healthcare offers innovative products, digital dashboards, service and training to help hospitals standardize processes to keep patients and staff safe, and reduce the costs and inefficiencies of infections.
For more information on OxyCide Daily Disinfectant Cleaner, visit Ecolab.com.
A trusted partner at nearly three million customer locations, Ecolab (ECL) is the global leader in water, hygiene and energy technologies and services that protect people and vital resources. With annual sales of $15 billion and 49,000 associates, Ecolab delivers comprehensive solutions and on-site service to promote safe food, maintain clean environments, optimize water and energy use, and improve operational efficiencies for customers in the food, healthcare, energy, hospitality and industrial markets in more than 170 countries around the world. www.ecolab.com